1-2 of 2
Cecile Idink
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

COVID-19 vaccination in patients with immune thrombocytopenia

Clinical Trials & Observations
Chantal Visser, Maurice Swinkels, Erik D. van Werkhoven, F. Nanne Croles, Heike S. Noordzij-Nooteboom, Matthijs Eefting, Suzanne M. Last-Koopmans, Cecile Idink, Peter E. Westerweel, Bart Santbergen, Pieter A. Jobse, Fazil Baboe, RECOVAC-IR Consortium, Peter A. W. te Boekhorst, Frank W. G. Leebeek, Mark-David Levin, Marieke J. H. A. Kruip, A. J. Gerard Jansen
Journal: Blood Advances
Blood Adv (2022) 6 (6): 1637–1644.
https://doi.org/10.1182/bloodadvances.2021006379
Published: 2022
Includes: Supplemental data
Journal Articles

Obinutuzumab pretreatment abrogates tumor lysis risk while maintaining undetectable MRD for venetoclax + obinutuzumab in CLL

Clinical Trials & Observations
Arnon P. Kater, Sabina Kersting, Yvette van Norden, Julie Dubois, Johan A. Dobber, Clemens H. Mellink, Ludo M. Evers, Fransien Croon-de Boer, John Schreurs, Ellen van der Spek, Hein Visser, Cecile Idink, Shulamiet Wittebol, Mels Hoogendoorn, Sanne H. Tonino, Mehrdad Mobasher, Mark-David Levin
Journal: Blood Advances
Blood Adv (2018) 2 (24): 3566–3571.
https://doi.org/10.1182/bloodadvances.2018019422
Published: 2018
Includes: Supplemental data